Riverview Trust Company’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$171K Hold
800
0.21% 63
2025
Q4
$137K Hold
800
0.16% 73
2025
Q3
$107K Hold
800
0.13% 85
2025
Q2
$77.9K Sell
800
-290
-27% -$23K 0.1% 106
2025
Q1
$79.2K Hold
1,090
0.08% 169
2024
Q4
$78.7K Sell
1,090
-20
-2% -$1.52K 0.07% 178
2024
Q3
$90.6K Buy
1,110
+20
+2% +$1.74K 0.08% 173
2024
Q2
$116K Hold
1,090
0.11% 142
2024
Q1
$106K Buy
+1,090
New +$95.9K 0.08% 164
2023
Q4
Sell
-290
Closed -$18.2K 404
2023
Q3
$18.2K Hold
290
0.02% 428
2023
Q2
$18.6K Hold
290
0.02% 391
2023
Q1
$15.4K Hold
290
0.01% 459
2022
Q4
$12K Sell
290
-20
-6% -$837 0.01% 626
2022
Q3
$11K Buy
310
+30
+11% +$1.34K 0.01% 650
2022
Q2
$12K Sell
280
-820
-75% -$39K 0.01% 639
2022
Q1
$59K Buy
+1,100
New +$64K 0.04% 200

Other funds holding LRCX

Riverview Trust Company's LRCX Position: Q1 2026 in Review

Riverview Trust Company held its Lam Research (LRCX) position steady in Q1 2026 at 800 shares worth $171K. The position accounts for 0.21% of the portfolio, ranked #63.

Riverview Trust Company first reported a position in LRCX in Q1 2022 and has held it in 16 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Riverview Trust Company held 800 shares of Lam Research worth $171K as of Q1 2026.
  • Riverview Trust Company left its Lam Research share count unchanged in Q1 2026.
  • Lam Research made up 0.21% of Riverview Trust Company's portfolio in Q1 2026, its #63 holding.
  • Riverview Trust Company first reported a position in Lam Research in Q1 2022 and has held it in 16 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Riverview Trust Company's 13F filing for Q1 2026, filed 1 May 2026.